Scoping meeting for the development of guidelines on screening for active TB
31 May - 1 June 2011
The WHO Stop TB Department organized a scoping meeting for the development of guidelines on screening for active TB, in Geneva 31 March and 1 June.
The objectives of the meeting were:
1. To review available evidence on screening for active TB disease
2. To agree on the type, scope, and set timeline for development of global guidelines on screening for active TB disease
3. To identify key knowledge gaps and suggested additional analysis of secondary data, which could be completed during 2011-2012, and inform the guideline development.
The meeting reviewed available evidence on TB screening; agreed on the scope for TB screening guidelines; identified key knowledge gaps; and formulated questions for additional systematic reviews and other analyses of secondary data that could be performed over the next 6-12 months to inform the guideline development.
The meeting agenda, presentations and draft report are presented below.
Meeting presentations
Session 1: The rationale for TB screening
-
Meeting background and objectives
pdf, 416kb -
Historical perspective on TB screening and lessons for the future
pdf, 398kb -
Active case finding for leprosy elimination: lessons for TB
pdf, 731kb -
Lessons from TB prevalance surveys and the role of chest X-ray in TB screening
pdf, 1.33Mb -
New diagnostics and their potential role in TB screening/diagnostic algorithms
pdf, 1.60Mb
Session 2: Systematic review findings
-
Systematic review of number needed to screen in selected risk groups with different screening approaches
pdf, 1.68Mb -
Screening for TB in people with HIV – implication for policy of meta analysis and modelling results
pdf, 648kb
Session 3: Country experiences of TB screening
Session 4: Regional perspectives
-
Experiences and policy development on TB screening in Europe
pdf, 645kb -
Experiences and policy development on TB screening in the Western Pacific Region
pdf, 1.98Mb -
EU perspective
pdf, 391kb
Session 5: Modelling and other analyses
-
Modelling impact of TB screening I
pdf, 1.61Mb -
Knowledge gaps that can be filled with modelling and other analyses
pdf, 861kb
Session 6: Guideline development plans